MESO
Mesoblast Limited
NASDAQ · Healthcare · Biotechnology · AU
$17.32
+1.05%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 149.44x
- P/S forward
- 144.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.96x
- Price / sales
- 18.65x
- Price / cash flow
- -54.53x
Enterprise value
- Enterprise value
- $2.3B
- EV / sales
- 18.86x
- EV / EBITDA
- -50.61x
- EV / EBIT
- -19.28x
- Market cap
- $2.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026